Samsung Bioepis’ Ko Insists On Value Of Data

Real-World Evidence Is Essential In Bolstering Biosimilars

 
• By David Wallace
  
Doctor_Hand_Screen
Real-world data is key to build confidence in biosimilars, Ko says • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business